Accessibility Menu
Novo Nordisk A/s logo

Novo Nordisk A/s

(OTC) NONOF

Current Price$42.22
Market Cap$187.60B
Since IPO (2003)+166%
5 Year+14%
1 Year-38%
1 Month-5%

Novo Nordisk A/s Financials at a Glance

Market Cap

$187.60B

Revenue (TTM)

DKK 327.62B

Net Income (TTM)

DKK 121.90B

EPS (TTM)

$4.26

P/E Ratio

9.90

Dividend

$1.80

Beta (Volatility)

0.52 (Low)

Price

$42.22

Volume

4,829

Open

$42.50

Previous Close

$42.22

Daily Range

$42.19 - $42.90

52-Week Range

$34.00 - $82.50

NONOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Nordisk A/s

Industry

Pharmaceuticals

Employees

68,794

CEO

Maziar Mike Doustdar

Headquarters

Bagsvaerd, 2880, DK

NONOF Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

45%

Net Income Margin

37%

Return on Equity

74%

Return on Capital

44%

Return on Assets

22%

Earnings Yield

10.10%

Dividend Yield

4.28%

Payout Ratio

42.47%

Stock Overview

Market Cap

$187.60B

Shares Outstanding

4.44B

Volume

4.83K

Avg. Volume

182.85K

Financials (TTM)

Gross Profit

DKK 247.74B

Operating Income

DKK 134.71B

EBITDA

DKK 149.10B

Operating Cash Flow

DKK 118.83B

Capital Expenditure

-DKK 60.00B

Free Cash Flow

DKK 58.83B

Cash & ST Invst.

DKK 26.90B

Total Debt

DKK 137.88B

Novo Nordisk A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

DKK 96.82B

+24.0%

Gross Profit

DKK 83.23B

+27.7%

Gross Margin

85.96%

N/A

Market Cap

$187.60B

N/A

Market Cap/Employee

$2.42M

N/A

Employees

77,406

N/A

Net Income

DKK 48.56B

+67.2%

EBITDA

DKK 69.21B

+50.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

-DKK 124.76B

-61.7%

Accounts Receivable

DKK 100.27B

+44.4%

Inventory

DKK 51.35B

+19.8%

Long Term Debt

DKK 119.17B

+23.7%

Short Term Debt

DKK 27.21B

+21.4%

Return on Assets

21.81%

N/A

Return on Invested Capital

44.45%

N/A

Free Cash Flow

DKK 12.05B

+20.4%

Operating Cash Flow

DKK 24.08B

-2.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVSEFNovartis AG
$144.14+0.00%
FSNUYFresenius SE & Co. KGaA
$10.51-1.37%
ESLOFEssilorLuxottica S.A.
$201.48+2.73%
CSLLYCSL Limited
$16.35-1.68%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$16.73-0.01%
NVTSNavitas Semiconductor
$30.84+0.19%
NUNu Holdings
$11.64-0.02%
XOSXos
$7.46+2.35%

Questions About NONOF

What is the current price of Novo Nordisk A/s?

Novo Nordisk A/s is trading at $42.22 per share.

What is the 52-week range for Novo Nordisk A/s?

Over the past 52 weeks, Novo Nordisk A/s has traded between $34.00 and $82.50.

How much debt does Novo Nordisk A/s have?

As of the most recent reporting period, Novo Nordisk A/s reported total debt of DKK 22.57B.

How much cash does Novo Nordisk A/s have on hand?

Novo Nordisk A/s reported DKK 3.26B in cash and cash equivalents in its most recent financial results.

What is Novo Nordisk A/s’s dividend yield?

Novo Nordisk A/s currently has a dividend yield of 4.28%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.